Showing results (251-260 of 364) with videos related to
Sort By:
Pageof 37
Journal of the American Chemical Society|July 24, 2018
Chiral Cyclohexyl-Fused Spirobiindanes: Practical Synthesis, Ligand Development, and Asymmetric CatalysisZhiyao Zheng, Yuxi Cao, Qinglei Chong, et al.Plos One|September 3, 2010
Identification of novel inhibitors of dietary lipid absorption using zebrafishJustin D Clifton, Edinson Lucumi, Michael C Myers, et al.The Journal of Pharmacology and Experimental Therapeutics|March 17, 2016
Characterization of Brain-Penetrant Pyrimidine-Containing Molecules with Differential Microtubule-Stabilizing Activities Developed as Potential Therapeutic Agents for Alzheimer's Disease and Related TauopathiesJane Kovalevich, Anne-Sophie Cornec, Yuemang Yao, et al.Molecular Pharmacology|June 28, 2020
Structural Refinement of the Tubulin Ligand (+)-Discodermolide to Attenuate Chemotherapy-Mediated SenescenceBoying Guo, Alicia Rodriguez-Gabin, Andrea E Prota, et al.Journal of Virology|December 10, 2020
Stabilizing the HIV-1 envelope glycoprotein State 2A conformationDani Vézina, Shang Yu Gong, William D Tolbert, et al.Bioorganic & Medicinal Chemistry Letters|July 28, 2007
Identification and characterization of 3-substituted pyrazolyl esters as alternate substrates for cathepsin B: the confounding effects of DTT and cysteine in biological assaysMichael C Myers, Andrew D Napper, Nuzhat Motlekar, et al.Journal of Medicinal Chemistry|April 16, 2010
Discovery of brain-penetrant, orally bioavailable aminothienopyridazine inhibitors of tau aggregationCarlo Ballatore, Kurt R Brunden, Francesco Piscitelli, et al.Accounts of Chemical Research|February 8, 2014
Structure-based design, synthesis and validation of CD4-mimetic small molecule inhibitors of HIV-1 entry: conversion of a viral entry agonist to an antagonistJoel R Courter, Navid Madani, Joseph Sodroski, et al.Science (New York, N.Y.)|October 31, 2024
A solution to the anti-Bredt olefin synthesis problemLuca McDermott, Zach G Walters, Sarah A French, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|March 8, 2024
Bioactive peptide relieves glucocorticoid-induced osteoporosis by giant macrocyclic encapsulationYuna Shang, Qingrun Zhu, Jiaming Ding, et al.Pageof 37